[Combined radio-immuno-chemotherapy for medulloblastoma].
The authors studied 10 cases of medulloblastoma by CT scan and reviewed treatment, result and pathological findings. Combined radio-chemo-immuno therapy (RAFP therapy: Radiation, ACNU, FT-207, PSK) resulted in 5 cases of complete remission and 4 cases of partial remission. In the most effective group, the tumor shadow disappeared after irradiation of 3,000 rad. In 2 cases the tumor shadow did not disappear after RAFP therapy, and total removal was performed. In pathological examination highly differentiated cell groups were recognized. For medulloblastomas we recommend a combination of radiation, chemotherapy and immunotherapy, such as RAFP therapy, and if the tumor shadow still remains, surgery.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000293:Adolescent; D000328:Adult; D002528:Cerebellar Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008527:Medulloblastoma / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D011509:Proteoglycans / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed
D000276:Adjuvants, Immunologic; D011509:Proteoglycans; C010770:polysaccharide-K